Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    64,046.25
    -453.30 (-0.70%)
     
  • CMC Crypto 200

    1,332.64
    -63.89 (-4.58%)
     
  • S&P 500

    5,106.35
    +57.93 (+1.15%)
     
  • Dow

    38,304.48
    +218.68 (+0.57%)
     
  • Nasdaq

    15,926.18
    +314.42 (+2.01%)
     
  • Gold

    2,352.10
    +9.60 (+0.41%)
     
  • Crude Oil

    83.69
    +0.12 (+0.14%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

How Dynavax Demolished Expectations With Its Q1 Results

How Dynavax Demolished Expectations With Its Q1 Results

Who wouldn't love a stock that has more than doubled in a little over five months? That's exactly what Dynavax Technologies (NASDAQ: DVAX) has done, thanks partially to good news in April for its COVID-19 vaccine partner Valneva.